Los Angeles Capital Management LLC Bridge Bio Pharma, Inc. Transaction History

Los Angeles Capital Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$24.02 - $43.89 $138,619 - $253,289	-5,771 Reduced 37.95%	9,436 $380,000
Q3 2023 Nov 06, 2023	SELL	$16.89 - $35.01 $137,687 - $285,401	-8,152 Reduced 34.9%	15,207 $401,000
Q2 2023 Aug 03, 2023	BUY	$13.29 - $18.01 $38,354 - $51,976	2,886 Added 14.1%	23,359 $401,000
Q1 2023 May 04, 2023	SELL	$7.17 - $18.55 $10,231 - $26,470	-1,427 Reduced 6.52%	20,473 $339,000
Q4 2022 Feb 06, 2023	SELL	$6.74 - $11.52 $17,247 - $29,479	-2,559 Reduced 10.46%	21,900 $166,000
Q3 2022 Nov 02, 2022	BUY	$7.94 - $12.36 $4,327 - $6,736	545 Added 2.28%	24,459 $243,000
Q2 2022 Aug 05, 2022	SELL	$5.21 - $12.14 $46,973 - $109,454	-9,016 Reduced 27.38%	23,914 $217,000
Q1 2022 May 06, 2022	BUY	$7.34 - $17.16 $150,470 - $351,780	20,500 Added 164.92%	32,930 $334,000
Q4 2021 Feb 03, 2022	SELL	$11.38 - $53.41 $1,536 - $7,210	-135 Reduced 1.07%	12,430 $207,000
Q3 2021 Nov 08, 2021	SELL	$46.87 - $64.24 $468 - $642	-10 Reduced 0.08%	12,565 $589,000
Q2 2021 Aug 05, 2021	SELL	$46.47 - $63.93 $32,529 - $44,751	-700 Reduced 5.27%	12,575 $767,000
Q1 2021 May 05, 2021	BUY	$55.47 - $72.35 $12,036 - $15,699	217 Added 1.66%	13,275 $817,000
Q4 2020 Feb 04, 2021	BUY	$38.38 - $71.11 $12,665 - $23,466	330 Added 2.59%	13,058 $929,000
Q3 2020 Nov 02, 2020	BUY	$27.2 - $42.19 $99,280 - $153,993	3,650 Added 40.21%	12,728 $478,000
Q2 2020 Aug 05, 2020	BUY	$22.22 - $35.69 $201,713 - $323,993	9,078 New	9,078 $296,000

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.